Target intelligence / Profile preview

Ubiquitin conjugating enzyme E2 V2 pseudogene 2 (UBE2V2P2)

Target
UBE2V2P2
Molecular classification
Other (Pseudogene)
01

Overview

Ubiquitin conjugating enzyme E2 V2 pseudogene 2 (UBE2V2P2) is a pseudogene, meaning it is a DNA sequence similar to protein-coding ubiquitin conjugating enzyme E2 V2 (UBE2V2), but it does not encode a functional protein product and has no known biological or therapeutic relevance. Pseudogenes typically arise from gene duplication or retrotransposition followed by accumulation of disabling mutations, rendering them transcriptionally or translationally inactive. Key clarification: If you are seeking information about a true, functional ubiquitin conjugating enzyme, you likely mean UBE2V2, an E2 ubiquitin-conjugating enzyme involved in post-translational modification of proteins via ubiquitination[2]. The suffix "P2" denotes a pseudogene variant and is not a therapeutic or functional target. Summary judgment: UBE2V2P2 is not a functional molecular target and should not be classified as such. There is nothing to suggest clinical, experimental, or molecular relevance beyond being a gene relic.

Beyond the preview

Go deeper on Ubiquitin conjugating enzyme E2 V2 pseudogene 2 (UBE2V2P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin conjugating enzyme E2 V2 pseudogene 2 (UBE2V2P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call